Uluslararası Sunular

Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler

1. CNGA3 mutations in cone photoreceptor disorders. Wissinger B, Gamer D, Jaegle H, Mayer S, Andreasson S, Rosenberg T, Jurklies B, Şener EC, Tatlıpınar S , et al. (American Journal of Human Genetics, 1999;65:498-Abstract no: 2840) The American Society of Human Genetics, 49th Annual Meeting, San Francisco, ABD,1999.

2. Quantitative analysis of apoptosis in retinoblastoma. Kıratlı H, Tatlıpınar S, Bilgiç S, Söylemezoğlu F. European Association for Vision and Research, Palma de Mallorca, İspanya, 2000 .

3. Retinal nerve fiber analysis (NFA) and interpretation of GDx parameters in patients with tilted disc syndrome. Bozkurt B, Tatlıpınar S , İrkeç M, Erdener U, Orhan M, Karaağaoğlu E, Gedik Ş. 6th Congress of the European Glaucoma Society, Londra, İngiltere, 2000.

4. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Yaylalı V, Demirlenk İ, Tatlıpınar S, Özbay D, Eşme A, Yıldırım C, Özden S. XX Congress of the ESCRS, Nice, Fransa, Eylül 2002.

5. Protective effects of ischemic preconditioning on retinal ischemia/reperfusion injury in rats. Özbay D, Özden S, Müftüoğlu S, Kaymaz F, Yaylalı V, Yıldırım C, Tatlıpınar S. 4th International Glaucoma Symposium, Barcelona, İspanya, Mart 2003.

6. Yıldırım C, Tatlıpınar S, Yaylalı V, Kıter E, Düzcan F, Özden S. Congenital fibrosis of extraocular muscles associated with musculoskeletal abnormalities. 29th Meeting of the European Strabismological Association, s.95, İzmir, Türkiye, 2004.

7. Tatlıpınar S, Shah S, Campochiaro PA, Nguyen QD. Reproducibility of optical coherence measurements in patients with neovascular age-related macular degeneration. Association for Research in Vision and Ophthalmology (ARVO 2005), s.206, Fort Lauderdale, A.B.D, 2005.

8. Nguyen QD, Shah S, Tatlıpınar S, Do DV, van Anden E , Campochiaro PA. Bevacizumab suppresses choroidal neovascularization secondary to pathologic myopia. Association for Research in Vision and Ophthalmology (ARVO 2005), s.59, Fort Lauderdale, A.B.D, 2005.

9. Akpek EK, Tatlıpınar S. Topical cyclosporin in the treatment of ocular surface disorders: an evidence-based update. Association for Research in Vision and Ophthalmology (ARVO 2005), s.115, Fort Lauderdale, A.B.D, 2005.

10. Shah S, Tatlıpınar S, Tabandeh H, Nguyen QD, Quinlan E, Zimmer-Galler I, Campochiaro PA. Quantitative fluorescein angiography for assessment of treatment effects in patients with choroidal neovascularization. Association for Research in Vision and Ophthalmology (ARVO 2005), s.60, Fort Lauderdale, A.B.D, 2005.

11. Quinlan E, Nguyen QD, Kaiser P, Young L, Gupta A, Shah SM, Tatlıpınar S, et al. A phase I, open-label, dose escalation trial of intravitreal injection of small interfering RNA molecule in subjects with neovascular AMD. American Academy of Ophthalmology Annual Meeting, s. 178, Chicago, A.B.D., 2005.

12. Nguyen QD, Tatlıpınar S, Shah SM, et al. Results of the phase I study of the safety, tolerability, and bioactivity of multiple intravitreal injections of ranibizumab in subjects with diabetic macular edema. 29th Annual Meeting of the Macula Society, s.170, San Diego, A.B.D., 2006.

13. Do DV, Nguyen QD, Tatlıpınar S, et al. Interim results of the READ study: ranibizumab for edema of the macula in diabetes. American Academy of Ophthalmology Annual Meeting, s. 279, Las Vegas, A.B.D., 2006.

14. Shah SM, Nguyen QD, Haller J, Tatlıpınar S, et al. Durability of ranibizumab effect in patients with diabetic macular edema. Association for Research in Vision and Ophthalmology (ARVO 2007), Fort Lauderdale, A.B.D, 2007.

15. Gorgun E, Yenerel NM, Dinç UA, Kucumen RB, Tatlıpınar S, Kulaçoğlu DN. Correlation between microperimetry and optical coherence tomography in idiopathic epiretinal membrane. 3rd Mediterranean Retina Meeting, İstanbul, 2008.

16. Utine CA, Tatlıpınar S, Gorgun E, Dinç UA, Yenerel NM, Alimgil L. Fundus autofluorescence findings in pigmented paravenous chorioretinal atrophy. 3rd Mediterranean Retina Meeting, İstanbul, 2008.

17. Ayata A, Ünal M, Tatlıpınar S, Erşanlı D, Bilge AH. Combined intracameral bevacizumab and photodynamic therapy for rubeosis. 3rd Mediterranean Retina Meeting, İstanbul, 2008.

18. Ayata A, Tatlıpınar S, Kar T, Ünal M Erşanlı D, Bilge AH. Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy. 3rd Mediterranean Retina Meeting, İstanbul, 2008.

19. Ayata A, Tatlıpınar S, Ünal M Erşanlı D, Bilge AH. Excitation-time dependent increment in the luminescence of fundus autofluorescence. 3rd Mediterranean Retina Meeting, İstanbul, 2008.